Loading... Please wait...

Our Newsletter

NVP-TAE684 | ALK inhibitor

  • NVP-TAE684.jpg
  • NVP-TAE684, 400x400px, png
Catalog #:

Product Description

NVP-TAE684 is an aminopyrimidine-based, ATP-competitive inhibitor of ALK (IC50, 3 nM) with additional activity vs Flt3 and Tie2 at values of 3 nM, and 12 nM, respectively. Despite ALK's high sequence homology with insulin receptor kinase (InsR), cellular InsR potency of NVP-TAE684 in Ba/F3 Tel-Flt3 and Ba/F3 Tel-Tie2 cell lines was 554 nM and >1 uM, respectively. [1]

In human anaplastic large-cell lymphoma (ALCL) cell lines expressing NPM-ALK, NVP-TAE684 inhibits proliferation of Karpas-29 and SU-D HL-1 cell lines with an IC50 range of 2-5 nM. Additionally, NVP-TAE684 inhibits phosphorylation of downstream of both ERK and Akt in Karpas-299 cells, thus aiding in the confirmation that STAT, RAS/FAR/MAPK, and PI3K/Akt are activated by NPM-ALK in ALCL cell lines.

NVP-TAE684 has been shown to be efficacious in neuroblastoma lines with constitutively active ALK mutations (G1128A, I1171N, F1174L, R1192P, F1245C, R1275Q). [2] Additionally, NVP-TAE684 is effective in crizotinib-resistant EML4-ALK L1196M mutants as well as other secondary gatekeeper mutations. [2]

Technical information:

Chemical Formula:   C30H40ClN7O3S
CAS #:   761439-42-3
Molecular Weight:   614.2
Purity:   >98%
Appearance:   Pale Yellow
Chemical Name:   5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine
Solubility:   Up to 15 mM in DMSO
Synonyms:   NVP-TAE684, TAE684, TAE-684

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


1. Galkin et al., Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc. Natl. Acad. Sci. 2007, 104(1), 270-275. Pubmed ID: 17185414
2. Schonherr et al., Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684. Biochem. J. 2011, 440, 405-413. Pubmed ID: 21838707
3. Katayama et al., Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK. Proc. Natl. Acad. Sci. 2011, 108(18), 7535-7540. Pubmed ID: 21502504

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.

Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Add to Wish List

Click the button below to add the NVP-TAE684 | ALK inhibitor to your wish list.

You Recently Viewed...